Caplin Point Laboratories Ltd

524742

Summary

Fair Value Assessment
Fairly Valued
Fair ValueQ1,987.22UncertaintyHigh
Close Price1,987.40Mar 26, 2025
Market Closed
1,987.40
Price Down by 68.80 | 3.35 %
Previous Close
1,987.40
Day Range
1,975.45 – 2,061.10
Year Range
1,221.00 – 2,636.00
Bid / Ask
Market Cap
151.1 Bil
Volume / Average
5.3 k / 9.6 k
Beta (5-Year)
0.70
Shares Outstanding
76.01 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
Contact
Ashvich Tower, Developed Plots Industrial Estate No. 3, 3rd Floor, Chennai, TN 600 096
T +91 4424968000
www.caplinpoint.net opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
4,882

Key Metrics

Income Statement (in Bil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
18.71 16.77 14.67 12.63 10.48 8.63
Revenue Growth %
15.69% 15.34% 15.54% 20.49% 24.12% 33.07%
Gross Profit
11.05 9.47 8.04 7.03 5.73 4.47
Gross Profit Margin %
59.05% 56.50% 54.78% 55.63% 54.68% 51.75%
Operating Income
5.62 5.01 3.96 3.50 2.93 2.30
Operating Margin %
30.02% 29.87% 27.00% 27.68% 27.98% 26.66%
EBIT
5.99 5.18 4.52 3.63 2.97 2.62
EBIT Margin %
32.04% 30.89% 30.83% 28.74% 28.29% 30.39%
EBITDA
6.65 5.71 4.97 4.10 3.34 2.94
EBITDA Margin %
35.53% 34.08% 33.89% 32.46% 31.82% 34.05%
Net Income
5.15 4.57 3.76 3.00 2.42 2.15
Net Profit Margin %
27.64% 27.52% 25.70% 24.42% 23.99% 24.92%
Basic EPS
67.82 60.19 49.62 39.61 32.03 28.42
Diluted EPS
67.45 59.90 49.18 39.26 31.71 28.20
Normalized EPS
67.29 59.68 49.67 39.94 32.20 26.36
Total Dividends per Share
5.00 4.50 4.00 3.00 0.40 4.30
Balance Sheet (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
29.24 26.98 21.91 17.36 13.64 11.26
Total Liabilities
3.50 3.51 2.84 2.26 1.60 1.69
Total Debt
0.02 0.02 0.05 0.02 0.18 0.39
Total Equity
25.75 23.47 19.07 15.10 12.03 9.57
Cash And Cash Equivalents
1.77 5.50 1.78 4.57 4.57 2.12
Working Capital
16.69 15.62 12.86 10.90 8.93 6.78
Shares Outstanding (Bil)
0.08 0.08 0.08 0.08 0.08
Book Value Per Share
284.36 247.75 175.88 125.99 95.25
Total Debt To Equity
0.00 0.00 0.00 0.00 0.02 0.04
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
3.75 3.18 2.72 3.37 2.66 0.45
Cash From Investing Activities
-2.97 -3.20 -2.18 -2.71 -0.05 -0.55
Cash From Financing Activities
-0.40 -0.38 -0.28 -0.41 -0.24 0.80
Capital Expenditures
1.46 1.94 0.91 0.70 0.77
Free Cash Flow
3.11 1.80 2.57 1.91 1.60
Change in Cash
0.38 -0.40 0.26 0.25 2.36 0.70

Profile

Name (Age)
5-Year Trend
2021
2022
2023
2024
2025
Sridhar Ganesan (—) Director and Managing Director
Total Compensation for all Key Executives
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership


© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top